Event Date/Time: Apr 26, 2004 End Date/Time: Apr 28, 2004
Report as Spam

Description

IBC’s Inaugural Conference on Early Development of Biotherapeutics: Successful Approaches for Managing Immunogenicity and Comparability, Interpreting Regulations and Guidances, and Implementing Process Changes has been developed to address the most important issues in the development of biotherapeutics by providing case studies, presentations by FDA regulators and detailed product development presentations by industry experts. IBC’s Inaugural Conference on Early Development of Biotherapeutics is conveniently held concurrently with IBC’s 8th International Intensive Symposium on Biological Assay Development & Validation. This creates a rare opportunity to share perspectives and strategies with hundreds of leaders in the industry through shared sessions featuring 5 case studies, luncheons, and a cocktail reception. To register or view full details for IBC’s Inaugural Conference on Early Development of Biotherapeutics, visit www.LifeSciencesInfo.com/3071. To register or view full details for IBC’s 8th International Intensive Symposium on Biological Assay Development & Validation, visit www.LifeSciencesInfo.com/3011.

Venue

1380 Harbor Island Drive
San Diego
California
United States
MORE INFO ON THIS VENUE

Restrictions

Types